CD34 and disease arising from reactivation of latent virus: However, the current drug compositions are not able to completely eliminate the virus [48], since HIV-1 is capable of maintaining latent infection in stable reservoirs such as resting CD4+ T cells, naive T cells and CD34+ multipotent hematopoietic stem cells [49, 50].